Rapid method for detection of minimal bactericidal concentration of antibiotics

Journal of Microbiological Methods

Volumn 77, Issue 1, 2009, Pages 85-89

  Bär, Werner ^a   Bäde Schumann, Ulrike ^a   Krebs, Andreas ^b   Cromme, Ludwig ^b  

^a CARL THIEM KLINIKUM   (Germany)

^b BRANDENBURG UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Fluorescence; Minimal bactericidal concentration

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; FLUORESCENT DYE; GENTAMICIN; MEROPENEM; PIPERACILLIN; PROPIDIUM IODIDE; SYTO 9; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; BACTERIUM DETECTION; BACTERIUM ISOLATION; BROTH DILUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EXPOSURE; ESCHERICHIA COLI; FLUORESCENCE ANALYSIS; MATHEMATICAL MODEL; METHODOLOGY; MICROTITER PLATE ASSAY; MINIMAL BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BACTERIA; FLUORESCENT DYES; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; STAINING AND LABELING;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA;

EID: 62349095294     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2009.01.010     Document Type: Article

References (28)

1. Allmann R., Hann A.C., Manchee R., and Lloyd D. Characterization of bacteria by multiparameter flow cytometry. J. Appl. Microbiol. 73 5 (1992) 438-444
2. Álvarez-Barrientos A., Arroyo J., Cantón R., Nombela C., and Sánchez-Pérez M. Applications of flow cytometry to clinical microbiology. Clin. Microbiol. Rev. 13 (2000) 167-195
3. Barenfanger J., Drake C., and Kacich G. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J. Clin. Microbiol. 37 (1999) 1415-1418
4. Bodey G.P. Pseudomonas aeruginosa infections in cancer patients: have they gone away?. Curr. Opin. Infect. Dis. 14 (2001) 403-407
5. Boulos L., Prévost M., Barbeau B., Coallier J., and Desjardins R. LIVE/DEAD BacLight TM: application of a new rapid staining method for direct enumeration of viable and total bacteria in drinking water. J. Microbiol. Methods 37 (1999) 77-86
6. Boye E., Steen H., and Skarstad K. Flow cytometry of bacteria: a promising tool in experimental and clinical microbiology. J. Gen. Microbiol. 129 (1983) 973-980
7. Cotter G., and Adley C.C. Comparison and evaluation of antimicrobial susceptibility testing of enterococci performed in accordance with six national committee standardized disk diffusion procedures. J. Clin. Microbiol. 39 (2001) 3753-3756
8. Cromme L.J. A unified approach to differential characterizations of local best approximations for exponential sums and splines. J. Approx. Theory 36 4 (1982) 294-303
9. De Girolami P.C., and Eliopoulos G. Antimicrobial susceptibility tests and their role in therapeutic drug monitoring. Clinics Lab. Med. 7 (1987) 499-513
10. Doern G., Staneck J., Needham C., and Tubert T. Sensititre autoreader for same-day breakpoint broth microdilution susceptibility testing of members of the family Enterobacteriaceae. J. Clin. Microbiol. 25 (1987) 1481-1485
11. Doern G., Vautour R., Gaudet M., and Levy B. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J. Clin. Microbiol. 32 (1994) 1757-1762
12. Food and Drug Administration. Review criteria for assessment of antimicrobial susceptibility devices. Revised draft document. Based on CFR 21 Part 807 subpart E for 510 (k) and CFR 21 Part 814 for PMA (1991), U.S. Food and Drug Administration, Rockville, Maryland
13. Fung-Tomc J., Gradelski E., Valera L., Kolek B., and Bonner D. Comparative killing rates of fluoroquinolones and cell wall-active agents. Antimicrob. Agents Chemother. 44 (2000) 1377-1380
14. Gant V., Warnes G., Phillips I., and Savidge G. The application of flow cytometry to the study of bacterial responses to antibiotics. J. Med. Microbiol. 39 (1993) 147-154
15. González-Barca E., Fernández-Sevilla A., Carratalá J., Salar A., Peris J., Grañena A., and Gudiol F. Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia. Eur. J. Clin. Microbiol. Infect. Dis. 18 (1999) 539-544
16. Hacek D., Dressel D., and Peterson L. Highly reproducible bactericidal activity test results by using a modified National Committee for Clinical Laboratory Standards broth macrodilution technique. J. Clin. Microbiol. 37 (1999) 1881-1884
17. Manome I., Ikedo M., Saito Y., Ishii K.K., and Kaku M. Evaluation of a novel automated chemiluminescent assay system for antimicrobial susceptibility testing. J. Clin. Microbiol. 41 (2003) 279-284
18. Mason D., Power E., Talsania H., Phillips I., and Gant V. Antibacterial action of ciprofloxacin. Antimicrob. Agents Chemother. 39 (1995) 2752-2758
19. Mason D., Allman R., Stark J., and Lloyd D. Rapid estimation of bacterial antibiotic susceptibility with flow cytometry. J. Microsc. 176 (1994) 8-16
20. Mortimer F., Mason D., and Gant V. Flow cytometric monitoring of antibiotic-induced injury in Escherichia coli using cell-impermeant fluorescent probes. Antimicrob. Agents Chemother. 44 (2000) 676-681
21. Mueller M., de la Peña A., and Derendorf H. Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC. Antimicrob. Agents Chemother. 48 (2004) 369-377
22. National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents. Tentative standard. National committee for clinical laboratory standards, M26-T Villanova, Pa (1999)
23. O'Shaughnessy E., Fahle G., and Witebsky F. Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli. J. Clin. Microbiol. 35 (1997) 1902-1903
24. Porter J., Deere D., Pickup R., and Edwards C. Fluorescent probes and flow cytometry: new insights into environmental bacteriology. Cytometry 23 (1996) 91-96
25. Raad I., Escalante C., Hachem R., Hanna H., Husni R., Afif C., Boktour M., Whimbey E., Kontoyiannis D., Jacobson K., Kantarjian H., Levett L., and Rolston K. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Cancer 98 (2003) 1039-1047
26. Rice J. The approximation of functions vol. 2: Nonlinear and multivariate theory (1969), Addison-Wesley Publishing Co., Reading, Mass.
27. Szabó D., Máthé A., Filetóth Z., Anderlik P., Rókusz L., and Rozgonyi F. In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain. Antimicrob. Agents Chemother. 45 (2001) 1287-1291
28. Virta M., Lineri S., Kankaanpää P., Karp M., Peltonen K., Nuutila J., and Lilius E. Determination of complement-mediated killing of bacteria by viability staining and bioluminescence. Appl. Environ. Microbiol. 64 (1998) 515-519